Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem

Overview of attention for article published in Drug Safety, July 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 18,011 followers.

Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem https://t.co/tFRHCnAb5D

RT @PORTAL_Research: New from @PORTAL_Research and @US_FDA in Drug Safety: Multimodal Analysis of FDA Drug Safety Communications: Lessons f…

RT @PORTAL_Research: New from @PORTAL_Research and @US_FDA in Drug Safety: Multimodal Analysis of FDA Drug Safety Communications: Lessons f…

New from @PORTAL_Research and @US_FDA in Drug Safety: Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem https://t.co/4FpCJYMX45